相比于男異性戀者,，男同性戀者的癌癥發(fā)病率較高,，相比于女異性戀癌癥存活者，女同性戀和女雙性戀癌癥存活者的健康水平較低,。這些是提前在線發(fā)表在《癌癥》期刊上的一篇最新研究得出的結(jié)論,，《癌癥》是“美國癌癥協(xié)會（American Cancer Society）”的同行評審期刊。研究結(jié)果闡明了用來幫助女同性戀,、男同性戀和雙性戀癌癥存活者改善健康水平的項目和服務(wù)類型,。
癌癥監(jiān)控研究不會詢問有關(guān)性取向的問題，這意味著有關(guān)多少癌癥存活者為女同性戀,、男同性戀或者雙性戀的信息非常稀少,。為了填補(bǔ)這一信息缺口，美國波士頓大學(xué)（Boston University）公共衛(wèi)生學(xué)院的Ulrike Boehmer博士及其同事根據(jù)不同的性取向在加利福尼亞州進(jìn)行了癌癥存活率的研究,。他們還調(diào)查了不同性取向的癌癥存活者的健康水平差異情況,。
本研究包括來自2001年、2003年和2005年的加利福尼亞州健康訪問調(diào)查的數(shù)據(jù)。該調(diào)查是美國最大規(guī)模的州級健康調(diào)查,，共有7252名成年女性和3690名成年男性報告了癌癥診斷,。研究人員在不同性取向的女性患者之間沒有發(fā)現(xiàn)顯著的癌癥發(fā)病率差異，但是相比于女異性戀癌癥存活者,，女同性戀和女雙性戀癌癥存活者報告不太好或很差的健康水平的可能性要分別高出2.0倍和2.3倍,。相比于男異性戀者，男同性戀者報告癌癥診斷的可能性要高出1.9倍,。男性癌癥存活者的自報健康水平?jīng)]有因為性取向的不同而出現(xiàn)顯著的差異,。
“這一信息可以用于開發(fā)針對女同性戀、男同性戀和雙性戀人群的服務(wù),，”Boehmer博士說道,。“因為更多的男同性戀患者報告為癌癥存活者，我們需要重點進(jìn)行針對男同性戀患者的原發(fā)癌癥預(yù)防和早期癌癥檢測項目,。因為相比于女異性戀癌癥患者,，更多的女同性戀和女雙性戀癌癥患者的健康水平很低，我們需要重點進(jìn)行改善女同性戀和女雙性戀癌癥患者的健康的項目和服務(wù),，”Boehmer博士說道,。
Boehmer博士指出，研究結(jié)果提出了未來研究應(yīng)該解決的問題,。比如說,，是不是由于更多的男同性戀者接受癌癥診斷，就意味著有更多的男同性戀者具有癌癥史呢,？或者相比于男異性戀者,，是不是有更多的男同性戀者能夠在確診為癌癥后存活呢？類似地,，女同性戀和女雙性戀患者接受癌癥診斷的可能性與女異性戀患者一樣嗎,？或者癌癥存活的相似性能否說明女同性戀和女雙性戀患者之間的存活率差別？（生物谷Bioon.com）
生物谷推薦原文出處：
CANCER DOI: 10.1002/cncr.25950
Cancer survivorship and sexual orientation
Ulrike Boehmer PhD1,*,?, Xiaopeng Miao MS2, Al Ozonoff PhD2
Keywords:cancer;survivorship;quality of life;prevalence;homosexuality
Abstract
BACKGROUND:
Lesbian, gay, and bisexual populations are not part of cancer surveillance, resulting in scarce information about the cancer survivorship of these populations. To address this information gap, the authors examined the prevalence of cancer survivorship by sexual orientation and cancer survivors' self-reported health by sexual orientation.
METHODS:
The authors explored these issues by analyzing pooled data from the California Health Interview survey from 2001, 2003, and 2005. By using descriptive statistics and logistic regressions, they examined the cancer prevalence in men and women by sexual orientation and subsequently compared the self-reported health of male and female cancer survivors by sexual orientation.
RESULTS:
Among women, the authors found no significant differences in cancer prevalence by sexual orientation, but lesbian and bisexual female cancer survivors had 2.0 and 2.3× the odds of reporting fair or poor health compared with heterosexual female cancer survivors. Among men, we found significant differences in cancer prevalence, with gay men having 1.9× the odds of reporting a cancer diagnosis compared with heterosexual men. There were no differences by sexual orientation in male cancer survivors' self-reported health.
CONCLUSIONS:
Our novel findings suggest sex differences in the impact of cancer on lesbian, gay, and bisexual cancer survivors. Lesbian and bisexual cancer survivors need to be targeted by programs and services to assist these cancer survivors in improving their health perceptions, whereas healthcare providers and public health agencies need to be made aware of the higher prevalence of cancer in gay men to prevent future cancers through increased screening and primary prevention.
